reference/15957255

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15957255

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	263
issn	1097-0142 0008-543X
issueIdentifier	2
pageRange	257-263
publicationName	Cancer
startingPage	257
bibliographicCitation	Lipton A, Leitzel K, Ali SM, Demers L, Harvey HA, Chaudri-Ross HA, Evans D, Lang R, Hackl W, Hamer P, Carney W. Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy. Cancer. 2005 Jul 15;104(2):257–63. doi: 10.1002/cncr.21202. PMID: 15952182.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dbb36b2c426e2f4af30dc7411fc409be http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54e84f85d110877ba01e71d460196488 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc6482b3d76e0f502633c7ce020c7141 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6220a52c4e2c7f4ef82971ce6e4c5e99 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_639e9ce8972c13680433f1312a28b46a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0ed717b5b9f680ebf96f4da580be2eba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c4ef18d8120c193d9907951b986c478 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8adec9ac4fc3d2303bf75198fe51e4e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33265d6cc8caab4dcd0c774703d43c04 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_add6d2740d1fc901e2425137066b8ac7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e1f050c670ffda65574078e6daab7aff
date	2005-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/15952182 https://doi.org/10.1002/cncr.21202
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2771 https://portal.issn.org/resource/ISSN/0008-543X https://portal.issn.org/resource/ISSN/1097-0142
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Serum HER‐2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy
discusses	http://id.nlm.nih.gov/mesh/M000640349 http://id.nlm.nih.gov/mesh/M0021024 http://id.nlm.nih.gov/mesh/M0014878 http://id.nlm.nih.gov/mesh/M0028300 http://id.nlm.nih.gov/mesh/M0021911 http://id.nlm.nih.gov/mesh/M0028048 http://id.nlm.nih.gov/mesh/M0456327 http://id.nlm.nih.gov/mesh/M0007791
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002277Q000097 http://id.nlm.nih.gov/mesh/D013629Q000627 http://id.nlm.nih.gov/mesh/D018931Q000627 http://id.nlm.nih.gov/mesh/D018719Q000097 http://id.nlm.nih.gov/mesh/D001943Q000097 http://id.nlm.nih.gov/mesh/D009570Q000627 http://id.nlm.nih.gov/mesh/D014230Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D001943Q000188 http://id.nlm.nih.gov/mesh/D001943Q000473 http://id.nlm.nih.gov/mesh/D001943Q000401 http://id.nlm.nih.gov/mesh/D004965Q000627 http://id.nlm.nih.gov/mesh/D002277Q000188 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D002277Q000473 http://id.nlm.nih.gov/mesh/D000077289 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D047072Q000627 http://id.nlm.nih.gov/mesh/D016019
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5d445780815638f183c8f68566998507 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3902

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128713593 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136182740

Total number of triples: 65.